$105.54 +3.14 (%) Gilead Sciences Inc - NASDAQ

Dec. 18, 2014 | 04:00 PM

Partner Headlines

  1. Is it Time to Sell Gilead Sciences?

    GuruFocus | Dec. 18, 2014 | 11:27AM EST
  2. Meet 5 Big Tech Stocks Expected To See Profits Surge

    IBD | Dec. 16, 2014 | 19:46PM EST
  3. Druckenmiller Adds Healthcare Stocks to Portfolio

    GuruFocus | Dec. 15, 2014 | 16:57PM EST
  4. Meet 5 Top Biotech Stocks Holding Up In Shaky Market

    IBD | Dec. 13, 2014 | 08:02AM EST
  5. These 2 Biotech Stocks Are Set To Split The $15 Billion Hepatitis C Market

    Benzinga | Dec. 12, 2014 | 11:44AM EST
  6. How Can Drugmakers Handle New Pricing Pressures?

    IBD | Dec. 11, 2014 | 17:38PM EST
  7. Gilead Sciences Bucks Trend In Biotech Short Interest

    Benzinga | Dec. 11, 2014 | 12:06PM EST
  8. 6 Strong Analyst Recommendations That You Should Know

    Benzinga | Dec. 11, 2014 | 11:49AM EST
  9. UPDATE: Morgan Stanley Raises PT on Gilead Sciences Following AlphaWise Survey

    Benzinga | Dec. 9, 2014 | 11:10AM EST
  10. T Rowe Price's Top Stakes for the Third Quarter

    GuruFocus | Dec. 9, 2014 | 10:16AM EST
  11. 3 Biotech ETFs Rally On Merger News

    Benzinga | Dec. 8, 2014 | 17:43PM EST
  12. 3 Strong Buys and Sells

    GuruFocus | Dec. 8, 2014 | 15:06PM EST
  13. Stocks Fall To Session Lows: GoPro Gives Up More Ground

    IBD | Dec. 8, 2014 | 13:25PM EST
  14. Stock Market Today: Jazz Hits New High, In Buy Range

    IBD | Dec. 8, 2014 | 12:02PM EST
  15. Stocks Mixed In Early Going; McDonald's Takes Heat

    IBD | Dec. 8, 2014 | 10:28AM EST
  16. Gilead Sciences Spikes Higher As Barron's Suggests Looking Beyond Hepatitis-C

    Benzinga | Dec. 5, 2014 | 10:50AM EST
  17. Hot Drugmakers Build More Labs, Grab Space In Boston

    IBD | Dec. 4, 2014 | 16:47PM EST
  18. Great News For Biogen, But What's Next For The Stock?

    Benzinga | Dec. 3, 2014 | 12:36PM EST
  19. Apple, Facebook: Jason Weiner Of Fidelity's View

    IBD | Dec. 2, 2014 | 18:19PM EST
  20. 5 Stock-Moving Medtech Events This December

    IBD | Nov. 28, 2014 | 14:18PM EST
  21. #PreMarket Primer: Wednesday, November 26: Big Retailers Gear Up For Black Friday

    Benzinga | Nov. 26, 2014 | 08:13AM EST
  22. Can Partnering To Fight Hepatitis C Pay At Entanta?

    IBD | Nov. 24, 2014 | 16:44PM EST
  23. Can Partnering To Fight Hepatitis C Pay At Enanta?

    IBD | Nov. 24, 2014 | 16:44PM EST
  24. AbbVie, Celgene, Sanofi Drugs Get EU Endorsements

    IBD | Nov. 21, 2014 | 12:28PM EST
  25. CNBC's Stock Pops & Drops From November 19

    Benzinga | Nov. 20, 2014 | 07:38AM EST
  26. Screening Pharma Stocks Amid Turnaround

    YCharts | Nov. 19, 2014 | 09:37AM EST
  27. Stock Movers: Why 4 Big Drug Stocks Are Rising Today

    IBD | Nov. 18, 2014 | 14:38PM EST
  28. Incyte Building Blockbuster Drug One Disease At A Time

    IBD | Nov. 17, 2014 | 15:58PM EST
  29. Weekly CFO Sells Highlight: Tableau Software Inc, Gilead Sciences Inc, Facebook Inc.

    GuruFocus | Nov. 16, 2014 | 22:36PM EST
  30. Julian Robertson's Tiger Management 13F Reveals Huge Alibaba Stake

    Benzinga | Nov. 15, 2014 | 09:57AM EST
  31. Biotech Stocks Hit: Stock Market To See New Leaders?

    IBD | Nov. 14, 2014 | 18:22PM EST
  32. CNBC's Stock Pops & Drops From November 13: King Digital, Alibaba, SanDisk, Gilead Sciences

    Benzinga | Nov. 14, 2014 | 07:25AM EST
  33. Gilead Sciences In Correction Mode

    Benzinga | Nov. 13, 2014 | 13:37PM EST
  34. Here Are The Top 25 Analysts On Wall Street

    Benzinga | Nov. 13, 2014 | 10:47AM EST
  35. Momentum Investing By Sub-Sector: 1990 To Now

    YCharts | Nov. 13, 2014 | 04:04AM EST
  36. Fast Money Halftime Report Final Trade From November 12: Twitter, Dunkin Brands, Gilead Sciences

    Benzinga | Nov. 12, 2014 | 15:58PM EST
  37. Gilead Sciences Releases Impressive Results for Hepatitis C Drug

    GuruFocus | Nov. 12, 2014 | 11:56AM EST
  38. #PreMarket Primer: Wednesday, November 12: Banks Fined More Than $3 Billion For Role In Forex Manipulation

    Benzinga | Nov. 12, 2014 | 07:44AM EST
  39. Gilead up on Harvoni results

    IBD | Nov. 11, 2014 | 18:30PM EST
  40. Merck down on hep C data

    IBD | Nov. 10, 2014 | 19:00PM EST
  41. Shire CEO Looks Ahead To Independent Future

    IBD | Nov. 10, 2014 | 16:46PM EST
  42. Stock Movers: Why These 5 Top Stocks Are Rising Today

    IBD | Nov. 10, 2014 | 14:04PM EST
  43. Gilead, Price Controls' Supporting Role in the Midterms

    FoxBusiness | Nov. 10, 2014 | 13:00PM EST
  44. Merck Down On Hepatitis C Data; Gilead Rises

    IBD | Nov. 10, 2014 | 11:14AM EST
  45. RBC Sees Weak Merck Data As Positive For Gilead

    Benzinga | Nov. 10, 2014 | 09:29AM EST
  46. Premarket: Stock Futures Mixed; Gilead Climbs On Merck News

    IBD | Nov. 10, 2014 | 08:59AM EST
  47. Stock Movers: Why Medicals Issues Are Dipping Today

    IBD | Nov. 7, 2014 | 15:26PM EST
  48. Humana Misses On ObamaCare Spending, Hep C Drug Costs

    IBD | Nov. 7, 2014 | 10:32AM EST
  49. Why Gilead Sciences' Bull Run Should Continue

    GuruFocus | Nov. 6, 2014 | 12:51PM EST
  50. Three Attractively Priced Small Cap Biotech Stocks

    GuruFocus | Nov. 5, 2014 | 12:45PM EST
Trading Center